Ubuhlungu besifuba obuhambisana ne-Erectile Dysfunction Drugs

Uma Ifika ku-ED, Kubalulekile Ukumanga Nokutshela

Ukukhubazeka kwe-Erectile kuthinta abantu abangu-22% abangaphezu kuka-40 e-United States. Njengoba kunabantu abangaphezu kwezigidi ezingu-64 abangaphezu kuka-40 e-US, lokho kusho ukuthi cishe abayizigidi ezingu-14 kubo banenkinga yokuthola ukulungiswa.

Izidakamizwa ze-Erectile Dysfunction

Lokho kuchaza ukuthi kungani izidakamizwa ze- erectile ukungasebenzi kahle zithinta kakhulu. Lezi zidakamizwa - eyaziwa ngokuthi i-Viagra, Cialis, ne-Levitra-zonke zivela ekilasini lemithi ebizwa nge-PDE5 inhibitors.

Ekuqaleni wadala ukusiza iziguli ezinesifo senhliziyo, lezi zidakamizwa zaba nomthelela ohlangothini oluthile owawuzuzisa kakhulu kunokusebenzisa kwawo kwasekuqaleni.

Inkinga nge-PDE5 inhibitors ukuthambekela kwabo ukuxhumana nezinye izidakamizwa ezenza isenzo esifanayo emzimbeni. I- nitrolycerin iyona evame kakhulu) kubangela ukuthi imithwalo yegazi ihlaziye - ukwandisa usayizi futhi ithwale igazi elingenakuphikisa. Ama-nitrate asiza imisipha yenhliziyo isebenze kakhudlwana ngenkathi ivumela igazi eliningi kumzimba wesisindo, okusho ukuthi iziguli ezinesifo esifubeni senhliziyo (angina) zingathatha i-nitroglycerin ukwenza ubuhlungu babo buphele.

I-PDE5 inhibitors isebenza ngendlela efanayo. Ngeshwa, uma uxuba ama-inhibitors e-PDE5 ne-nitroglycerin, imiphumela ingaba kabili noma kathathu futhi ibangele ukulahla okungazelelwe kwengozi yegazi . Ukuhlanganiswa kwalezi zinhlobo ezimbili zezidakamizwa kuyingozi kakhulu, i-American Heart Association iphakamisa ukuthi iziguli akufanele zithathe i-nitroglycerin zingakapheli amahora angu-24 ukuthatha i-PDE5 inhibitors.

Ngaphambi kokuba uthathe i-inhibitor ye-PDE5, udinga ukuxoxa nodokotela wakho ukuze uqonde ukuxhumana phakathi kwaleli klasi lemithi kanye neminye imithi ongase uyithathe.

Ukudalulwa okugcwele

Ukuqonda indlela lezi zigaba ezimbili zemithi ehlanganyela ngayo kubalulekile ngisho nakwabantu abangathathi i-nitrate.

Ngihlale ngithi kufanele ubize 911 ubuhlungu besifuba . Uma kwenzeka uthatha i-PDE5 inhibitor uma uthola ubuhlungu besifuba sakho, uzodinga ukutshela abaphenduli bokuphuthumayo.

Ukwelashwa okujwayelekile okuphuthumayo ukuhlunguphazwa kwesifuba esithinta inhliziyo kuhilela ukunikeza nitroglycerin ngokushesha. Ngaphambi kokunikeza noma imuphi umuthi, izimo eziphuthumayo kanye nabanye abahlinzeki bezempilo bafundiswa ukubuza mayelana nemithi yokwelapha. Kumele futhi bacele mayelana nama-inhibitors e-PDE5 ngaphambi kokunikeza i-nitroglycerin, kodwa lowo mbuzo awunakuzibuza ukubuza futhi abaphenduli abaningi ngeke.

Khulumela phezulu

Kudingeka ukhulume uma uthatha imithi ye-erectile ukungasebenzi, kungakhathaliseki ukuthi kungathandeki ukuthi kusho.

Bhala uhlu lwakho lwe-PDE5 inhibitor ohlwini lwakho lwemithi uma ugcina owodwa. Kungenzeka ukuthi ugcine umuthi endaweni ehlukile kunayo yonke imithi yakho - yisho kusikhathi sakho sokulala. Kuzodingeka usebenze uma ufuna ukuhlala uphephile.

Akuwona wonke ama-inhibitors e-PDE5 aphethwe yi-FDA, noma. Eqinisweni, i-FDA icele ukukhumbula ama Capsules we-True Man Sexual Energy Nutrient Amandla Amandla Amandla Amandla Amapulisi Amandla Amandla aseMein Energy Supplement, kokubili aqukethe izinguqulo ze-PDE5 inhibitors nakuba zikhangiswa ngokuthi "zonke izinhlobo zemvelo".

Uma uthatha izithako ezithinta ukuthuthukiswa kwesilisa noma ukwelashwa kwesifo sokungasebenzi kahle e-erectile khona-ke kudingeka udatshele izimo eziphuthumayo.

Kukawe, kodwa ngicabanga ukuthi ukuhlazeka kufanelekile ukugwema ukusebenzisana kwezidakamizwa ezibulalayo. Khumbula, kunabanye abayizigidi eziyi-14 ngaphandle lapho banesimo esifanayo; akuyona into yokuba namahloni.

> Imithombo:

> Laumann, EO, et al. "Ukusabalala kanye nama-Correlates wokungasebenzi kahle kwe-Erectile ngohlanga nobuhlanga phakathi kwamadoda aseMinyaka engu-40 noma asebekhulile e-United States: Ukusuka Kwimiqondo Yabesilisa Ngokuphathelene Nokusatshalaliswa Kwezempilo Ngocansi." I-Journal of Sexual Medicine . Jan 2007 PMID: 17081223

> "U-FDA Ucela Ukukhumbula 'Amandla Eqiniso Amandla Ezocansi,' 'Amandla Okudla Amandla Agesi'." 2 Novemba 2007. FDA News. I-FDA. 13 Novemba 2007

> Webb, DJ, et al. "I-sildrate yeSildenafil ne-Blood-Pressure-Lowering Drugs: Imiphumela Yezifundo Zokusebenzisana Nezidakamizwa Nge-Nitrate Engokwemvelo ne-Calcium Antagonist." I- American Journal of Cardiology. 4 Mar 1999 PMID: 10078539

> Kloner, RA "Ubulili Nesineke Ngezimo Zingozi Ze-Cardiovascular: Gxila ku-Sildenafil." I-American Journal of Medicine . 18 Dec 2000 PMID: 11137498

> O'Rourke, M, noJiang Xiong-Jing. "Sildenafil / Ukusebenzisana kwe-Nitrate." 2000. Amakhasi e-Circulation Electronic. I-AHA. 13 Novemba 2007